CLINICAL_TRIALS trial_result · 2024-03-01

Clinical Trial Update: A Study of JNJ-64281802 in Participants With Confirmed Dengue Fever [Phase 2]

Phase 2 trial of JNJ-64281802 for dengue fever was terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Janssen Research & Development, LLC | Conditions: Dengue | Phase 2 | Status: TERMINATED | Results posted: 2024-03-01